Do HDL particles transport omega-3 lipids and smaller HDL track with apoB/LDL excess?

High-density lipoprotein (HDL) particles are complex, functional platforms that dynamically remodel bioactive lipids. Their size distribution and composition serve as critical indicators of systemic metabolic health and cardiovascular risk.

Bioactive lipid transport and remodeling

• Enzymatic transformation: HDL incorporates dietary omega-3 fatty acids (EPA and DHA) and remodels them into specialized bioactive lipids like lysophosphatidylcholine-DHA (LPC-DHA) through the actions of lecithin-cholesterol acyltransferase (LCAT), endothelial lipase, and hepatic lipase.
• Targeted delivery: These remodeled lipids shift HDL subfractions toward larger, cardioprotective $HDL_2$ particles and are delivered to peripheral tissues via scavenger receptor BI (SR-BI) or transported across the blood-brain barrier via the Mfsd2a transporter.

Atherogenic particle alignment and metabolic remodeling

• Triglyceride exchange: Under conditions of insulin resistance, hepatic overproduction of large VLDL-1 particles accelerates CETP-mediated lipid exchange, swapping triglycerides into HDL and LDL in exchange for cholesteryl esters.
• Co-occurring elevations: Hepatic lipase subsequently hydrolyzes these triglyceride-rich particles, generating smaller, dense HDL alongside small dense LDL. This coordinated remodeling pathway results in a parallel excess of both apoB and LDL particle number (LDL-P).

Reverse lipid transport dynamics

• Size-dependent efflux: Small, lipid-poor HDL particles efficiently initiate macrophage cholesterol efflux via the ABCA1 transporter. However, larger, mature HDL particles are required to facilitate bulk cholesterol efflux and downstream transport via ABCG1 and SR-BI pathways.
• Impaired clearance: A depleted pool of large HDL particles limits global reverse lipid transport (RCT). Conversely, omega-3 fatty acid enrichment can restore RCT efficiency by modifying HDL composition, facilitating ABCA1-dependent efflux, and promoting hepatic clearance.

Bottom line

• Key takeaway: A lipid profile characterized by smaller HDL size and fewer large HDL particles serves as a key marker of atherogenic dyslipidemia, directly reflecting CETP-driven remodeling, elevated apoB and LDL-P, and compromised bulk reverse lipid transport.